to automated thin layer technology, changes in cervical cancer screening guidelines, increased utilization of fine-needle aspiration (FNA) and the resulting demand for rapid onsite evaluation (ROSE) of specimen adequacy have all impacted the role of cytotechnologists (CTs). CTs have adapted to these shifts in practice, technological advances, and the changing needs of the cytopathologists they support. At the same time, progress in technologies like tele-pathology and molecular testing will continue to influence cytotechnology practice.
With change comes ambiguity, and CTs have struggled with the trajectory of cytology's future for almost 2 decades. 1 Many strategies have been implemented and proposed to help CTs meet the changing needs of today while anticipating the needs of the future. Entry level competencies are periodically updated to meet expressed employer needs. 2, 3 Development of certificate courses for advanced training and a new doctoral degree all have been suggested and explored.
One concept of growing interest has been the development of an advanced practitioner for cytotechnology, often referred Since its inception, the profession of cytotechnology has progressed beyond the traditional roles of cytopreparation and Papanicolaou test screening. The evolution of Papani-colaou test collection from a manually smeared sample on a slide to as a cytopathology practitioner (CP) or mid-level pathology practitioner (MLPP). First discussed in 2005 and appealing as a potential career path for CTs, this practitioner would capitalize on the fundamental and somewhat unique skills of the CT-microscopic morphologic identification and depth of understanding of benign and neoplastic disease processes, while also encompassing more nontraditional tasks, expanding the scope of practice for these professionals.
These strategies hold promise for cytotechnologists while also presenting their own unique challenges for imple-mentation. In addition, concrete data on market demand and costebenefit evaluation are lacking, creating a stumbling block in progressing in this direction.
In an effort to identify professional trends while offering meaningful resources to support decision making in the cytopathology community, the American Society for Cytopathology (ASC) and the American Society for Clinical Pathology (ASCP) created the ASC/ASCP Workgroup: Focusing on Emerging Roles in Cytopathology. Developed in 2014, the workgroup charges include developing concrete goals to address evolving practice changes while ensuring education, practice, and trending data support the cyto-technology profession's longevity and livelihood.
To this end, the ASC/ASCP Workgroup initiated several data collection activities to assess the current state of CT practice and professional trends. This information is intended to inform the development of education and workforce model(s) from evidence-based recommendations and strategies to support current and future practitioners.
Materials and Methods
Research was conducted through a mixed-method data collection effort. These included:
1. The ASCP Board of Certification (BOC) Practice Analysis, used to evaluate current CT workforce and practice patterns. Information related to the ASCP BOC Cytotechnologist Practice Analysis survey is addressed in a separate publication. 4 2. Focus groups used to gather qualitative data regarding the perceptions and experiences of current stakeholders in cytopathology through face-to-face discussion.
3. A RAND Delphi study conducted to gather additional qualitative data to understand the perspectives and "pulse" of decision makers influencing cytopathology practice.
Focus Groups
The collection of qualitative data through the use of focus groups provides a means for participants to express their thoughts and opinions about the study topic in a face-toface environment. 5 For this study, 12 focus groups were conducted to solicit feedback from CTs regarding their experiences and perceptions about the future of the cytotechnology profession. Funding to support focus groups was provided through an ASC Foundation grant.
The ASC/ASCP Workgroup collaborated with a data evaluation, measurement, and assessment expert to prepare a script and series of questions to conduct the focus groups. The questions encompassed current and future CT roles, emerging nontraditional CT roles, the role of pathology extenders (such as pathologist assistants [PAs]), and the role of professional societies with respect to the future of the cytopathology/pathology profession ( Table 1) .
Members of the ASC Workgroup and the ASCP Evalu-ation, Measurement Assessment team were trained to facilitate focus groups. Techniques to prevent moderators from introducing bias into the conversation, to help ensure full participation from all focus group members, and to redirect discussion that strayed from the topic question were part of the training. For each session, one trained facilitator served as the moderator and another group member served as note-taker.
Professional society conferences provided the ideal setting to solicit participants for the focus groups. Meetings that attracted target audiences were identified ( • What is your role in meeting these needs? What is the role of other physician extenders in meeting these needs? • Do you feel prepared to meet these needs? Why? • What would help you meet these needs in practice?
• Do you feel one particular group is better prepared to meet these needs?
Future practice and role of CT/advanced practitioner
• Imagine cytotechnology practice in the next 15 years.
• What will be the role of cytotechnology/cytopathology in medicine/healthcare?
• What is the role of the CT (PA/physician extenders) in the lab? Will there be any changes from the current role?
• What types of duties will CTs perform? What is needed to get there?
• What promising initiatives (training, duties, roles) have you seen or heard about related to the future of cytology? What is the impact on roles that might be filled by the future "advanced cytotechnology professionals"? Role of professional societies the discussion. Although it is a time consuming process for both the participants and those who conduct the study, the blinded Delphi approach allows respondents to be candid while avoiding direct confronta-tion with the other experts. 7 In selecting study participants, a deliberate effort was made to include cytopathology professionals in leadership and decision making roles from a wide range of facility types. Workgroup members evaluated several sources from which to select Delphi participants, including directors of cytopathology fellowship programs and membership lists from the ASC and the Association of Directors of Anatomic and Surgical Pathology (ADASP), which were provided by the Workgroup sponsor organizations. The demographic information of Delphi study participants is summarized in
Figs. 1-4. These thought leaders were employed in a variety of practice settings, including commercial laboratories, academic institutions, and community hospitals. To encourage participation through study completion, participants were incentivized with gift cards and cytopa-thology textbooks.
The first round of questions in the Delphi study were developed and vetted by the ASC Workgroup in collaboration with the ASCP Data Evaluation, Measurement, and Assessment team ( 
Results

Focus Groups
One hundred six (106) volunteers participated in a total 12 focus groups conducted across 7 professional meeting loca-tions ( cytopathology fellows (27.3%; 3 of 11). Over half (54.5%; 6 of 11) of participating pathologists worked in academic medical centers, and 2 (18.2%) others worked in community hospital and corporate industry. Over half of CT respondents did not report demographic information regarding their employment facility type or years in practice (60%, 40 of 67; and 72%, 48 of 71; respectively); 3 (27.3%) pathologists did not provide information regarding their fa-cility of employment. One non-US CT and 3 (2.8%; 3 of 106) PAs also participated in the focus groups and provided par-allel comparisons.
Delphi Study
Fifty individuals were invited to participate in the first round of the Delphi study. Of the 50 individuals invited, 21 (42%) completed the full study process, which is within the range of the majority of Delphi studies. The initial round of questions was launched in late March 2016; the survey remained available until May 2016. The second round was launched in August 2016 and remained available until November 2016.
Research findings from the focus groups and Delphi data collection studies are summarized in Fig. 6 and Table 3 .
Discussion
Information gathered through all three data collection efforts revealed common themes, discussed in the following sections.
Cytotechnologists are Valued in the Workplace
Pathologists express in both Delphi and focus groups the importance of cytotechnologists in the laboratory to efficient workflow and quality patient care. CTs' pre-screening and morphologic/interpretive skills are reported as "invaluable to the pathology laboratory", such that a loss of traditional CT skills in the laboratory "would be detrimental to turn around time and overwhelming for pathologist workload." As pathologist extenders, CTs contribute to quality labora-tory services by assisting with FNA collection/processing/ preliminary review (sometimes independently) of FNA biopsies and training of cytotechnologists, residents, and fellows. One respondent commented that CTs are "pro-fessionals (who) have worked towards a focused, higher level of skill set to provide diligence, commitment, and quality to uphold higher standards." As such, pathologists have supported CTs to assist in managing other laboratory areas (histology and molecular pathology), quality assur-ance, and regulatory compliance activities.
CT Workforce Challenges
Participants report multiple challenges affecting the cyto-technology workforce. The BOC practice survey revealed a 28.3% decrease in performance of conventional Papanico-laou tests, 4 likely due to changes in technology and cervical cancer screening guidelines contributing to a diminishing need for CTs in traditional gynecologic
Figure 4
Number of Years Delphi Study Participants Involved in Cytology Practice screening settings. Although the BOC survey does not solicit laboratory volume, it does record tests that are performed, and con-ventional Papanicolaou test screening has declined with increasing implementation of liquid-based Papanicolaou test platforms and automated screening instruments. Participants also report that an increase in the use of molecular diagnostics, as well as changes in health care delivery structures, such as the consolidation of laboratory services within health care systems and changes in reimbursement rules, are challenges impacting the CT workforce. One Delphi participant feared the capitation of insurance re-imbursements could have a detrimental effect on the CT workforce, stating "small to medium size centers will find it extremely difficult to compete with giant corporate cost structures. This will crumble small services and demand for CTs will continue to reduce." Other laboratory leaders in both the focus groups and Delphi survey reported enhanced opportunities for CTs, responding to these changing and evolving practices by leveraging CTs morphologic and analytical skills sets and being "proactive in our training and utilization of CTs in high complexity roles throughout our laboratories." In contrast, a subset of CTs who participated in focus group discussions report they are not in laboratories that provide them with these same opportunities, high-lighting a divergence in practice based on geographic laboratory location, facility type, practice niches, and needs.
Current and Evolving Scope of Practice
Delphi and focus group studies reveal that CTs continue to practice in traditional roles. CTs also report more involvement in non-traditional roles since 2009, however. 4 Many performing non-traditional roles report that necessary training to work in these areas was provided directly by the laboratories in which they work. Some new/recent CT graduates who trained in CT programs offering an enhanced curriculum report they are not necessarily working directly in these areas (ie, molecular pathology), supporting the suggestion that the extent of CT involvement in non-traditional roles is dependent on several factors, including laboratory practice type and available opportunities.
There are limitations for focus groups that include study CTs and their co-workers (cytopathologists and program directors) are open to role expansion, although a few respondents expressed discomfort, less interest, or unwill-ingness to adopt new roles. CTs report increasing partici-pation in quality assurance and quality control activities, accreditation management, FNA, fluorescence in-situ hybridization (FISH), and immunohistochemical (IHC) and molecular tasks. Overall, lab personnel shortages, lab-oratory consolidations, and alleviation of pathologist duties are reported as contributing factors to expanded roles. Extent of CT involvement in non-traditional roles appears to be dependent on multiple factors such as laboratory practice setting, geographic laboratory location, and willingness of pathologists/lab managers to delegate and train CTs to perform these non-traditional tasks. The current regulatory and policy environment also prevents expanded roles in some laboratory areas. 8 • Profession of cytotechnology has undergone change due to falling Papanicolaou test volumes and technological advancements • Some cytotechnologists and supervisors report a mismatch between their training and employer
needs. There appears to be a lack of awareness of educaƟon curriculum updates among established and mid-career cytotechnologists and supervisors that were trained prior to the implementaƟon of revised entry-level competencies and other educaƟonal opportuniƟes.
• Cytotechnologists are performing tasks beyond Pap tests in their day-to-day responsibiliƟes by applying their skills in non-tradiƟonal tasks and other contexts not typically associated with cytology.
• Policy, regulatory, and reimbursement issues are recognized barriers to transiƟon for possible emerging roles.
Figure 6.
Focus Group Key Findings • Proactively training CTs in new roles. One lab considers CTs physician extenders for FNAs.
• Non-traditional roles in FNA, Molecular, digital photography, ROSE, FISH mentioned. Traditional roles: Negative urine and PAP sign-out.
• A few respondents reported that some CTs do not want to change or adopt new roles.
• Less comfort reported by some with delegating diagnostics, sign-outs, FNA Experienced CTs in mid-career or supervisory roles report a mismatch between their training and current employer needs. Whereas cytotechnology training programs periodically modify entry-level curriculum for new CTs to meet the needs of employers, experienced CTs who are design and small sample size. Focus groups are aimed at identifying common themes across groups, using methods such as data triangulation and constant comparisons. By nature of design, focus groups identify perceptions, opin-ions, and conceptual themes rather than fact or quantity of information. Analysis of focus group qualitative data via written notes and discussion recordings is voluminous, sometimes challenging to translate and centered on the group versus individual responses. Additionally, focus group participation is self-selected and results may not necessarily reflect the larger population.
When determining locations for focus groups, an attempt was made to host sessions at meetings where stakeholders beyond the cytopathology community have a higher rate of representation, in particular PAs and medical directors, who were not necessarily cytopathologists or pathology program directors. However, additional focus groups of such stakeholders would strengthen the data collected.
The Delphi method of surveying also has limitations. By design, Delphi studies involve a low number of participants. Isomorphism, or the selection of participants with the same perspective and views, may limit data gathering and repre-sentation of the full spectrum of the cytopathology community. Because of multiple feedback requests and the time required from participants, the dropout rate is an additional shortcoming of the Delphi process. However, despite a small study pool, the depth of responses collected adds validity to the study.
Our findings confirm that many currently practicing CTs are already performing tasks that were not included in their initial cytotechnology training, such as digital image analysis of DNA ploidy and FISH, review of IHC/special stains, and identification and selection of cytologic and histologic material for molecular testing. Although there is a mechanism to ensure that CT students receive current and relevant training through entry level competency revisions, 2, 3 there is a training gap for CTs who may be responsible for performing expanded roles but for whom there are no available formal training or certificate programs. Training subsequent to graduation from a cytotechnology program is highly variable. Some laboratories will provide onsite training; for others, professional organizations fill the role; and for some, there are limited opportunities to train in new tasks.
One of the challenges for professional organizations moving forward is to bridge this gap and provide an avenue for education and training that is affordable, accessible, and recognized in a way that allows them to compete in the workplace. That task is underway through the education domain of the ASC Workgroup and merits a separate discussion. 9 Controversial tasks for future CTs that have been discussed as part of the role of an advanced cytology practitioner (under the continued direction and supervision of a pathologist) include cytology sample collection (FNA performance of palpable lesions in patients without medical contraindications), provision of preliminary interpretations during ROSE, and sign-out of negative non-gynecologic specimens.
1 Anecdot-ally, there seem to be 2 schools of thought on this professional model: If We Build It, It Will Come-design a new degree category and the market will choose to use it; or Leave It Alone-current CTs are already performing many of the roles that have been proposed in advanced practitioner models, so demand for this degree will need careful evaluation against the scope of practice for current CTs and for market acceptance. In addition, federal regulatory and state licensure requirements currently restrict the expansion of many of these suggested roles. 8 Further studies are important to demonstrate need and quantify value if these potential tasks are to move into the CT scope of practice.
Conclusion
Study findings confirm changing practice patterns in cytopathology. CTs are increasingly performing roles within the laboratory that extend beyond their formal training and bridging the gap between their formal education and these new responsibilities. Although many laboratory leaders embrace the use of cytotechnologists in expanded roles, others show reluctance. Regulatory restrictions and reimbursement rules also continue to be barriers to expanded roles for CTs. This study examines current marketplace needs and cytotechnologists' perceptions of their evolving workplace demands through surveys and focus groups. Despite the limi-tations of the study, it provides a snapshot of the current climate of cytopathology and provides data that will help direct future education, personnel competency, and staffing decisions. LM
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